Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Dala Energi DE Apr 24, 2025 108.00 -0.46   
 Dedicare B DEDI Apr 24, 2025 44.50 -4.71   
 Desenio DSNO Apr 24, 2025 0.17 -13.70   
 DevPort DEVPB Apr 24, 2025 22.60 -0.44   
 Devyser Diagnostics DVYSR Apr 24, 2025 97.90 +0.93   
 DexTech Medical DEX Apr 24, 2025 4.06 +0.50   
 Diadrom Holding DIAH Apr 24, 2025 7.95 +3.25   
 Diagonal Bio DIABIO Apr 24, 2025 0.01 0.00   
 Diamyd Medical B DMYDB Apr 24, 2025 7.73 -0.90   
 Dicot Pharma AB DICOT Apr 24, 2025 0.31 +5.63   
 Dignitana DIGN Apr 24, 2025 2.05 +3.54   
 DistIT DIST Apr 24, 2025 2.16 +8.00   
 District Metals Corp. DMXSESDB Apr 24, 2025 2.04 0.00   
 Dividend Sweden AB DIVB Apr 24, 2025 0.20 -7.01   
 Divio Technologies B DIVIOB Apr 24, 2025 0.18 +5.88   
 Diös Fastigheter DIOS Apr 24, 2025 65.55 +0.23   
 Dlaboratory Sweden DLAB Apr 24, 2025 2.66 +1.53   
 DOF Group DOFGO Apr 24, 2025 80.60 +3.33   
 Dometic Group DOM Apr 24, 2025 34.80 -1.19   
 Doro DORO Apr 24, 2025 34.25 +0.59   
 Double Bond Pharmaceutical B DBPB Apr 24, 2025 0.27 -7.77   
 Doxa DOXA Apr 24, 2025 0.34 -2.87   
 Drillcon DRIL Apr 24, 2025 5.78 -1.03   
 Dug Foodtech DUG Apr 24, 2025 1.28 -7.22   
 Duni DUNI Apr 24, 2025 96.60 -0.10   
 Duroc B DURCB Apr 24, 2025 16.00 0.00   
 Dustin Group DUST Apr 24, 2025 3.58 +1.07   
 Dynavox Group AB DYVOX Apr 24, 2025 56.70 +1.07   
 Eastnine EAST Apr 24, 2025 42.70 +0.59   
 EasyFill B EASYB Apr 24, 2025 0.13 -1.56   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.